SEC Form 4 · accession 0001192482-15-000452
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne Weisman
Director
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 2:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.41 | Dec 16, 2015 | A | 10,000 | A | — | Dec 16, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option vests on December 16, 2016.